Understanding the evolving treatment landscape of hidradenitis suppurativa: An analysis of All of Us.

ABSTRACT: Hidradenitis suppurativa (HS) is a chronic skin condition with significant burden for affected patients. The development of new therapies in the last decade has brought hope for better patient outcomes, but understanding the use of these new drug classes is necessary to ensure patient access to care. We analysed data from 2636 HS patients within NIH's All of Us research program from June 2017 and October 1, 2023 to examine the likelihood of patients receiving certain classes of drugs based on socio-demographic factors and comorbid health conditions, as well as how these drug classes impact quality of life. We also examined trends in the number of prescriptions over time. Antibiotics were most frequently prescribed, with higher numbers administered to females. Small molecule inhibitors and

SUBMITTER: Gupta AK 

PROVIDER: S-EPMC12373187 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature